PMID: 11874396Mar 5, 2002Paper

Patient reporting of potential adverse drug reactions: a methodological study

British Journal of Clinical Pharmacology
Narumol JarernsiripornkulA Lee


To develop a systematic generic method of enabling patients to report symptoms which they believe to be due to a particular prescribed drug. A piloted body system-based questionnaire was distributed to patients registered with 79 medical practices in Grampian prescribed one of nine recently marketed 'black triangle' drugs. These comprised four antidepressants, three antiepileptics and two analgesics. This requested respondents to identify any symptoms experienced over the previous year which they thought could be due to the 'black triangle' drug they had used. A sample of medical records was examined to compare symptoms recorded with those reported by patients. A classification system was developed for the study to enable the assessment of symptoms reported for their potential relationship to patients' drug therapy. All symptoms reported were classified, taking into account information provided by patients on their concomitant drugs and diseases. A specialist pharmacist independently re-classified a sample of the symptoms to validate the process. A 36.3% response rate was obtained (837/2307) with 742 respondents (88.6%) reporting at least one symptom. The median per patient was 6.0 (range 0--71), with almost half (406, 48.5%) r...Continue Reading


Aug 17, 1979·JAMA : the Journal of the American Medical Association·M S KramerA R Feinstein
Oct 15, 1977·British Medical Journal·A B Wilson
Jul 1, 1975·Journal of Clinical Pharmacology·S N Ciccolunghi, H A Chaudri
Jul 1, 1992·The Annals of Pharmacotherapy·D M CorsoJ F Gallelli
Jul 1, 1990·Clinical Pharmacology and Therapeutics·S Fisher, S G Bryant
Oct 8, 1988·BMJ : British Medical Journal·A S MitchellD L O'Connell
Dec 1, 1988·Journal of the American Geriatrics Society·L E Kazis, R H Friedman
Jul 1, 1988·British Journal of Clinical Pharmacology·M D Rawlins
Jul 1, 1988·British Journal of Clinical Pharmacology·M D Rawlins
Jul 1, 1988·Archives of Internal Medicine·A S RogersG Faich
Nov 1, 1987·Journal of Clinical Pharmacology·S FisherR M Kluge
Sep 1, 1970·The Journal of Clinical Pharmacology and the Journal of New Drugs·K Rickels, R W Downing
Sep 1, 1970·The Journal of Clinical Pharmacology and the Journal of New Drugs·R W DowningF Meyers
Mar 1, 1995·The Annals of Pharmacotherapy·E G TimmT H Grasela
Apr 1, 1995·The Annals of Pharmacotherapy·J A GeneraliS E Rosenbaum
Dec 30, 1993·The New England Journal of Medicine·W A RayJ Avorn
Sep 11, 1993·Lancet·W Inman, G Pearce
Jan 1, 1993·European Journal of Clinical Pharmacology·J HallasF Frølund
Jul 1, 1993·The Annals of Pharmacotherapy·T R Einarson
Aug 31, 1996·BMJ : British Medical Journal·T C EgbertsH G Leufkens
Nov 21, 1997·BMJ : British Medical Journal·C K MannesseT J van der Cammen
Dec 31, 1997·Cancer Nursing·J SitziaN Winterberg
Mar 21, 1998·Critical Care Medicine·P FrassinelliM Rhodes
May 30, 1998·JAMA : the Journal of the American Medical Association·T J MooreC D Furberg
May 10, 2001·JAMA : the Journal of the American Medical Association·K A Calis, C E Daniels
Aug 7, 2001·International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services·W M al-Shaqha, M Zairi
Nov 1, 1996·Pharmacoepidemiology and Drug Safety·P C WallerS M Wood

❮ Previous
Next ❯


Nov 13, 2002·Pharmacoepidemiology and Drug Safety
Jul 4, 2009·Pharmacy World & Science : PWS·Narumol JarernsiripornkulJanet Krska
Jan 26, 2011·The Journal of Cardiovascular Nursing·Ruth H E De SmedtTiny Jaarsma
Oct 11, 2012·Cancer Nursing·Canhua XiaoDeborah Watkins Bruner
Feb 7, 2009·International Journal of Clinical Practice·R H E De SmedtT Jaarsma
Feb 22, 2012·Annals of Intensive Care·Maité Garrouste-OrgeasB Misset
Jan 24, 2014·Science Translational Medicine·Thomas J Urban, David B Goldstein
Feb 18, 2014·European Journal of Clinical Pharmacology·Nataporn ChaipichitNarumol Jarernsiripornkul
Jul 17, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Arnaud PagesHaleh Bagheri
Apr 5, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Sieta T de VriesPetra Denig
May 24, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Janet Krska, Charles W Morecroft
Oct 2, 2012·Journal of the American Pharmacists Association : JAPhA·Daniel R TouchetteScott R Smith
Sep 10, 2015·Pharmacoepidemiology and Drug Safety·Narumol JarernsiripornkulJanet Krska
Feb 24, 2009·Cancer Treatment Reviews·Manuela Schmidinger, Christoph C Zielinski
Aug 15, 2014·Health and Quality of Life Outcomes·Sieta T de VriesPetra Denig
May 3, 2003·European Journal of Pain : EJP·Narumol JarernsiripornkulPhillip A G Capps
Jul 15, 2009·British Journal of Clinical Pharmacology·Nicky Britten
Oct 11, 2008·The Journal of Clinical Hypertension·Steven G Chrysant
Feb 6, 2007·British Journal of Clinical Pharmacology·A BlenkinsoppP A Routledge
Jan 17, 2009·Pharmacoepidemiology and Drug Safety·N JarernsiripornkulJ Krska
May 20, 2011·Journal of Clinical Pharmacy and Therapeutics·H FortnumUNKNOWN Yellow Card Study Collaboration
Aug 3, 2011·Pharmacoepidemiology and Drug Safety·Janet KrskaCraig Wilson
Apr 19, 2011·British Journal of Clinical Pharmacology·Claire AndersonUNKNOWN Yellow Card Study Collaboration
May 29, 2013·British Journal of Clinical Pharmacology·Caitriona CahirTom Fahey
Feb 10, 2010·Journal of Cardiac Failure·Ruth H E De SmedtPetra Denig
Jan 30, 2015·International Journal of Clinical Pharmacy·Nataporn ChaipichitNarumol Jarernsiripornkul
Jan 13, 2015·International Journal of Clinical Pharmacy·Jarernsiripornkul NarumolJanet Krska
Dec 27, 2011·Revista de calidad asistencial : organo de la Sociedad Española de Calidad Asistencial·J J MiraJ Aranaz-Andrés
Jul 15, 2011·São Paulo Medical Journal = Revista Paulista De Medicina·Kazeem Adeola OshikoyaIyabo Ojo
Aug 21, 2009·Journal of Medical Economics·Lusine Breitscheidel, Sabine Stamenitis
Sep 28, 2017·PloS One·Fatemeh Saheb Sharif-AskariKheirollah Gholami
Oct 28, 2018·International Journal of Clinical Pharmacy·Sirinya KampichitNarumol Jarernsiripornkul
Feb 27, 2008·Pharmacoepidemiology and Drug Safety·Juliet M FosterPhilip Hannaford
Dec 4, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Christine Bond, Philip Hannaford
Jun 4, 2010·Critical Care Medicine·David C Stockwell, Sandra L Kane-Gill
May 23, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Asia N RashedAntje Neubert
Sep 26, 2020·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Joanne Barnes, Rachael Butler
Feb 17, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Tim W A SchoenmakersPeter A G M de Smet
Mar 1, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kees van GrootheestLolkje T W de Jong-van den Berg

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.